BioPremier
Thrives to become a global reference in producing and developing kits for diagnostics' laboratories.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 23 % | 2 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | 15 % | 11 % | 5 % |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
BioPremier, founded in 2003 by Manuel Rodrigues and headquartered in Amadora, Portugal, is a specialized provider of molecular biology and DNA sequencing services primarily for the food sector. In December 2016, global testing and certification leader SGS acquired a 70% stake in the company, a significant milestone that integrated BioPremier's specialized technologies into a worldwide network. This partnership followed years of informal cooperation and aims to combat food fraud and verify authenticity across the value chain.
The company's core business revolves around developing and manufacturing diagnostic kits and providing analytical services to a client base of private and government-owned laboratories. A key revenue stream is the Original Equipment Manufacturer (OEM) production of molecular biology kits, where BioPremier manufactures products under its clients' brands. This allows laboratories to expand their portfolios without direct investment in new facilities or technology. The company operates an ISO 17025 accredited laboratory, underscoring its commitment to quality standards.
BioPremier's flagship technology is based on Next Generation Sequencing (NGS), which facilitates the comprehensive identification of species such as meat, seafood, plants, allergens, and microorganisms present in food products, even if they are highly processed. Unlike targeted methods, the NGS workflow can answer the broader question of "what is in my sample?" by generating millions of DNA sequences in a single analysis. Beyond food safety and authenticity, the product portfolio extends to real-time PCR detection kits, DNA/RNA extraction and purification solutions, and various laboratory consumables for the human and veterinary diagnostic sectors as well.
Keywords: molecular biology, DNA sequencing, food safety, Next Generation Sequencing (NGS), food authenticity, OEM diagnostic kits, laboratory services, real-time PCR, food fraud detection, species identification, molecular diagnostics, ISO 17025, agri-food sector, veterinary diagnostics, DNA extraction kits, SGS, pathogen detection, allergen testing, microbial DNA, food testing laboratory